FRI0131 ELUCIDATING THE MECHANISM UNDERLYING CREATINE PHOSPHOKINASE UPREGULATION WITH UPADACITINIB
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.7509
Abstract: Background: JAK inhibitors, including Upadacitinib (UPA), have been associated with increased serum levels of creatine phosphokinase (CPK) in patients with inflammatory disorders, but not in patients with myeloproliferative disease or in healthy subjects treated for… read more here.
Keywords: differentiation; employee abbvie; cpk; may hold ... See more keywords